Tag: Chemotherapy
ASCO: FOLFOX Noninferior to Chemoradiotherapy for Overall Survival in Rectal Cancer
Findings seen in patients with locally advanced rectal cancer who were eligible for sphincter-sparing surgery
Many Cancer Centers Experiencing Shortage of Carboplatin, Cisplatin
93 percent of centers surveyed experiencing shortage of carboplatin, 70 percent experiencing shortage of cisplatin
Risk for Heart Failure Higher in Young Adult Cancer Survivors
Risk highest for those treated with anthracycline chemotherapy
Chinese Company May Help Ease U.S. Shortage of Cancer Drug
When importing drugs, the FDA stressed that regulators carefully assess product quality and manufacturing processes to ensure patient safety
ASCO: Adding Pembrolizumab to Chemo Improves Survival in Cervical Cancer
Overall and progression-free survival increased for persistent, recurrent, or metastatic cervical cancer
Cabozantinib Plus Nivolumab and Ipilimumab Increases PFS in Renal Cell Cancer
Progression-free survival significantly longer with addition of cabozantinib in previously untreated advanced renal cell carcinoma
Venetoclax-Obinutuzumab With, Without Ibrutinib Superior in Leukemia
Combination better than chemoimmunotherapy for percentage with undetectable minimal residual disease, PFS in chronic lymphocytic leukemia
Cemiplimab + Chemotherapy Aids Quality of Life With Lung Cancer
Improvement seen compared with chemotherapy alone for first-line treatment of advanced non-small cell lung cancer
Patient-Centered Approach Recommended for Oligometastatic NSCLC
Integration of definitive local therapy relevant if technically feasible and clinically safe to all disease sites
Black Patients More Likely to Have Heart Damage Following Chemo
Compared with White patients, Black patients have 71 percent higher odds of cardiotoxicity
